Lysoway Therapeutics

Lysosomal ion channel modulators for neurodegenerative diseases

Cambridge, United States · Founded 2020 · $3.4M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$3.4M
Last Round
$3.4M GrantJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Lysoway Therapeutics is a biotechnology company pioneering therapeutics targeting lysosomal ion channels for age-related neurodegenerative diseases. Based in Cambridge, Massachusetts and founded in 2020, the company develops potent small-molecule modulators of lysosomal ion channels such as TRPML1 and TMEM175, aiming to restore autophagy/lysosomal function to treat Parkinson's disease and rare diseases characterized by toxic cellular waste accumulation. Lysoway's lead program is a brain-penetrant, orally bioavailable TRPML1 agonist in preclinical/translational development, supported by grants from the Michael J. Fox Foundation.

Summary

Lysoway Therapeutics is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $3.4M in total across 1 round, most recently a $3.4M Grant round in Jun 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantMichael J. Fox Foundation Research GrantJun 2026
$3.4M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lysoway Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/lysoway-therapeutics"><img src="https://indexed.vc/api/badge/company/lysoway-therapeutics" alt="Lysoway Therapeutics on Indexed.vc" width="260" height="76" /></a>